366 related articles for article (PubMed ID: 18591484)
1. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.
Brennan AR; Arnsten AF
Ann N Y Acad Sci; 2008; 1129():236-45. PubMed ID: 18591484
[TBL] [Abstract][Full Text] [Related]
2. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
Arnsten AF
J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
[TBL] [Abstract][Full Text] [Related]
3. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
Arnsten AF
CNS Drugs; 2009; 23 Suppl 1():33-41. PubMed ID: 19621976
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine influences on dorsolateral prefrontal cortical networks.
Arnsten AF
Biol Psychiatry; 2011 Jun; 69(12):e89-99. PubMed ID: 21489408
[TBL] [Abstract][Full Text] [Related]
5. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
Arnsten AF; Pliszka SR
Pharmacol Biochem Behav; 2011 Aug; 99(2):211-6. PubMed ID: 21295057
[TBL] [Abstract][Full Text] [Related]
6. Stimulants: Therapeutic actions in ADHD.
Arnsten AF
Neuropsychopharmacology; 2006 Nov; 31(11):2376-83. PubMed ID: 16855530
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.
Arnsten AF
J Pediatr; 2009 May; 154(5):I-S43. PubMed ID: 20596295
[TBL] [Abstract][Full Text] [Related]
8. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.
Arnsten AF; Li BM
Biol Psychiatry; 2005 Jun; 57(11):1377-84. PubMed ID: 15950011
[TBL] [Abstract][Full Text] [Related]
9. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.
Berridge CW; Devilbiss DM
Biol Psychiatry; 2011 Jun; 69(12):e101-11. PubMed ID: 20875636
[TBL] [Abstract][Full Text] [Related]
10. The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.
Arnsten AF
Expert Rev Neurother; 2010 Oct; 10(10):1595-605. PubMed ID: 20925474
[TBL] [Abstract][Full Text] [Related]
11. Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.
Arnsten AFT
Neurobiol Learn Mem; 2020 Dec; 176():107327. PubMed ID: 33075480
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine regulation of the prefrontal cortex.
Arnsten AF
J Psychopharmacol; 1997; 11(2):151-62. PubMed ID: 9208378
[TBL] [Abstract][Full Text] [Related]
13. Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.
Arnsten AF
Cereb Cortex; 2007 Sep; 17 Suppl 1():i6-15. PubMed ID: 17434919
[TBL] [Abstract][Full Text] [Related]
14. Aberrant regulation of synchronous network activity by the attention-deficit/hyperactivity disorder-associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex.
Zhong P; Liu W; Yan Z
J Physiol; 2016 Jan; 594(1):135-47. PubMed ID: 26541360
[TBL] [Abstract][Full Text] [Related]
15. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex.
Wang M; Ramos BP; Paspalas CD; Shu Y; Simen A; Duque A; Vijayraghavan S; Brennan A; Dudley A; Nou E; Mazer JA; McCormick DA; Arnsten AF
Cell; 2007 Apr; 129(2):397-410. PubMed ID: 17448997
[TBL] [Abstract][Full Text] [Related]
16. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
Arnsten AF; Scahill L; Findling RL
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):393-406. PubMed ID: 17822336
[TBL] [Abstract][Full Text] [Related]
17. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell VA
Behav Brain Res; 2002 Mar; 130(1-2):191-6. PubMed ID: 11864734
[TBL] [Abstract][Full Text] [Related]
18. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
Emond V; Joyal C; Poissant H
Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
[TBL] [Abstract][Full Text] [Related]
19. What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function.
Sullivan RM; Brake WG
Behav Brain Res; 2003 Nov; 146(1-2):43-55. PubMed ID: 14643458
[TBL] [Abstract][Full Text] [Related]
20. Prefrontal cortex dysfunction in hypoxic-ischaemic encephalopathy contributes to executive function impairments in rats: Potential contribution for attention-deficit/hyperactivity disorder.
Miguel PM; Deniz BF; Deckmann I; Confortim HD; Diaz R; Laureano DP; Silveira PP; Pereira LO
World J Biol Psychiatry; 2018 Oct; 19(7):547-560. PubMed ID: 28105895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
